In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens

por Harding, Sarah V., Barnes, Kay B., Hawser, Stephen, Bentley, Christine E., Vente, Andreas
Publicado 2023

Efficacy of finafloxacin in a murine model of inhalational glanders

por Barnes, Kay B., Bayliss, Marc, Davies, Carwyn, Richards, Mark I., Laws, Thomas R., Vente, Andreas, Harding, Sarah V.
Publicado 2022

Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei

por Barnes, Kay B., Hamblin, Karleigh A., Richards, Mark I., Laws, Thomas R., Vente, Andreas, Atkins, Helen S., Harding, Sarah V.
Publicado 2017

The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4

por Barnes, Kay B., Hamblin, Karleigh A., Richards, Mark I., Laws, Thomas R., Vente, Andreas, Atkins, Helen S., Harding, Sarah V.
Publicado 2019

Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection

por Barnes, Kay B., Richards, Mark I., Laws, Thomas R., Núñez, Alejandro, Thwaite, Joanne E., Bentley, Christine, Harding, Sarah V.
Publicado 2021

Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague

por Hamblin, Karleigh A., Armstrong, Stuart J., Barnes, Kay B., Davies, Carwyn, Laws, Thomas, Blanchard, James D., Harding, Sarah V., Atkins, Helen S.
Publicado 2017

Investigation of a combination therapy approach for the treatment of melioidosis

por Barnes, Kay B., Richards, Mark I., Burgess, Gary, Armstrong, Stuart J., Bentley, Christine, Maishman, Thomas C., Laws, Thomas R., Nelson, Michelle, Harding, Sarah V.
Publicado 2022

The lytic transglycosylase, LtgG, controls cell morphology and virulence in Burkholderia pseudomallei

por Jenkins, Christopher H., Wallis, Russell, Allcock, Natalie, Barnes, Kay B., Richards, Mark I., Auty, Joss M., Galyov, Edouard E., Harding, Sarah V., Mukamolova, Galina V.
Publicado 2019

Demonstration of the Broad-Spectrum In Vitro Activity of Finafloxacin against Pathogens of Biodefense Interest

por Barnes, Kay B., Zumbrun, Steven D., Halasohoris, Stephanie A., Desai, Purvi D., Miller, Lynda L., Richards, Mark I., Russell, Paul, Bentley, Christine, Harding, Sarah V.
Publicado 2019

An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational Burkholderia pseudomallei

por Laws, Thomas R., Barnes, Kay B., Jenner, Dominic C., Núñez, Alejandro, Richards, Mark I., Thwaite, Joanne E., Vente, Andreas, Rushton, David, Nelson, Michelle, Harding, Sarah V.
Publicado 2022

Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever

por Hartley, M. Gill, Norville, Isobel H., Richards, Mark I., Barnes, Kay B., Bewley, Kevin R., Vipond, Julia, Rayner, Emma, Vente, Andreas, Armstrong, Stuart J., Harding, Sarah V.
Publicado 2021

In Vitro Activity of Novel Topoisomerase Inhibitors against Francisella tularensis and Burkholderia pseudomallei

por Whelan, Adam O., Cooper, Ian, Ooi, Nicola, Orr, David, Blades, Kevin, Kirkham, James, Lyons, Amanda, Barnes, Kay B., Richards, Mark I., Salisbury, Anne-Marie, Craighead, Mark, Harding, Sarah V.
Publicado 2023

The BALB/c Mouse Model for the Evaluation of Therapies to Treat Infections with Aerosolized Burkholderia pseudomallei

por Nelson, Michelle, Barnes, Kay B., Davies, Carwyn H., Cote, Christopher K., Meinig, J. Matthew, Biryukov, Sergei S., Dyer, David N., Frick, Ondraya, Heine, Henry, Pfefferle, Denise A., Horstman-Smith, Amanda, Barbaras, Julie, Harding, Sarah V.
Publicado 2023